Approaches to heart valve tissue engineering scaffold design

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 83, Issue 1, 2007, Pages 16-43

  Brody, Sarah ^a   Pandit, Abhay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Heart valve; Scaffold; Tissue engineering

Indexed keywords

CALCIFICATION (BIOCHEMISTRY); CARDIOVASCULAR SYSTEM; DISEASES; HEART VALVE PROSTHESES; HEMODYNAMICS; SCAFFOLDS;

CONGENITAL HEART DEFECTS; HEART VALVES; HEMODYNAMIC FLOW; NONCALCIFIC PROSTHETICS;

TISSUE ENGINEERING;

EXTRACELLULAR MATRIX; HEART VALVE PROSTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MORTALITY; NONHUMAN; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; VALVULAR HEART DISEASE;

ANIMALS; HEART; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; POLYMERS; PROSTHESIS DESIGN; STRESS, MECHANICAL; TISSUE ENGINEERING; TRANSPLANTATION, HOMOLOGOUS;

EID: 34648819507     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30763     Document Type: Review

References (107)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P. Heart disease and stroke statistics - 2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
2. Farivar RS, Filsoufi F, Adams DH. Mechanisms of Gal(α)1- 3Gal(β)1-4GlcNAc-R (αGal) expression on porcine valve endothelial cells. J Thorac Cardiovasc Surg 2003;125:306-314.
3. Yacoub MH, Kilner PJ, Birks EJ, Misfeld M. The aortic outflow and root: A tale of dynamism and crosstalk. Ann Thorac Surg 1999;68(3, Suppl):S37-S43.
4. Thubrikar MJ. The Aortic Valve. Boca Raton, FL: CRC Press; 1990. pp 23-24.
5. Howard IC, Patterson EA, Yoxall A. On the opening mechanism of the aortic valve: Some observations from simulations. J Med Eng Technol 2003;27:259-266.
6. Christie GW, Barratt-Boyes BG. Mechanical properties of porcine pulmonary valve leaflets: How do they differ from aortic valve leaflets? Ann Thorac Surg 1995;60:195-199.
7. Billiar KL, Sacks MS. Biaxial mechanical properties of the natural and glutaraldehyde treated aortic valve cusp. I. Experimental results. J Biomech Eng 2000;122:23-30.
8. Mulholland DL, Gotlieb AI. Cardiac valve interstitial cells: Regulator of valve structure and function. Cardiovasc Pathol 1997;6:167-174.
9. Filip DA, Radu A, Simionescu M. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 1986;59:310-320.
10. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A. Tissue engineering of heart valves - Human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 1998;14:279-284.
11. Gulbins H, Goldemund A, Anderson I, Haas U, Uhlig A, Meiser B, Reichart B. Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves. J Thorac Cardiovasc Surg 2003;125:592-601.
12. Dvorin EL, Wylie-Sears J, Kaushal S, Martin DP, Bischoff J. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: Proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor β1. Tissue Eng 2003;9:487-493.
13. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102(19, Suppl 3):III44-III49.
14. Zeltinger J, Landeen LK, Alexander HG, Kidd ID, Sibanda B. Development and characterization of tissue-engineered aortic valves. Tissue Eng 2001;7:9-22.
15. Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E, Simon P, Weigel G. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 2004;127:399-405.
16. Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S, Hubbell JA, Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000;17:587-591.
17. Ramamurthi A, Vesely I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 2005;26:999-1010.
18. Mendelson K, Schoen FJ. Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Ann Biomed Eng 2006;34:1799-1819.
19. Butcher JT, Penrod AM, Garcia AJ, Nerem RM. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol 2004;24:1429-1434.
20. Butcher JT, Nerem RM. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: Effects of steady shear stress. Tissue Eng 2006;12:905-915.
21. Magometschnigg H, Kadletz M, Vodrazka M, Dock W, Grimm M, Grabenwoger M, Minar E, Staudacher M, Fenzl G, Wolner E. Prospective clinical study with in vitro endothelial cell lining of expanded polytetrafluoroethylene grafts in crural repeat reconstruction. J Vasc Surg 1992;15:527-535.
22. Schneider PA, Hanson SR, Price TM, Harker LA. Confluent durable endothelialization of endarterectomized baboon aorta by early attachment of cultured endothelial cells. J Vasc Surg 1990;11:365-372.
23. Durbin AD, Gotlieb AI. Advances towards understanding heart valve response to injury. Cardiovasc Pathol 2002;11:69-77.
24. Stock UA, Schenke-Layland K. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials 2006;27:1-2.
25. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003;23:1002-1006; discussion 1006.
26. Ruiz CE, Iemura M, Medie S, Varga P, Van Alstine WG, Mack S, Deligio A, Fearnot N, Beier UH, Pavcnik D, Hijazi ZM, Kiupel M. Transcatheter placement of a low-profile biodegradable pulmonary valve made of small intestinal submucosa: A long-term study in a swine model. J Thorac Cardiovasc Surg 2005;130:477-484.
27. Vesely I. Heart valve tissue engineering. Circ Res 2005;97:743-755.
28. Bordenave L, Remy-Zolghadri M, Fernandez P, Bareille R, Midy D. Clinical performance of vascular grafts lined with endothelial cells. Endothelium 1999;6:267-275.
29. Sodian R, Hoerstrup SP, Sperling JS, Martin DP, Daebritz S, Mayer JE Jr, Vacanti JP. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. ASAIO J 2000;46:107-110.
30. Shinoka T. Tissue engineered heart valves: Autologous cell seeding on biodegradable polymer scaffold. Artif Organs 2002;26:402-406.
31. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60(6 Suppl):S513-S516.
32. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 1996;94(9 Suppl):II164-II168.
33. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valve leaflets: Does cell origin affect outcome? Circulation 1997;96(9 Suppl):II102-II107.
34. Zund G, Breuer CK, Shinoka T, Ma PX, Langer R, Mayer JE, Vacanti JP. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg 1997;11:493-497.
35. Kim WG, Cho SK, Kang MC, Lee TY, Park JK. Tissue-engineered heart valve leaflets: An animal study. Int J Artif Organs 2001;24:642-648.
36. Stock UA, Mayer JE Jr. Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. J Long Term Eff Med Implants 2001;11:249-260.
37. Kadner A, Hoerstrup SP, Tracy J, Breymann C, Maurus CF, Melnitchouk S, Kadner G, Zund G, Turina M. Human umbilical cord cells: A new cell source for cardiovascular tissue engineering. Ann Thorac Surg 2002;74:S1422-S1428.
38. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kolb SA, Grunenfelder J, Zund G, Turina MI. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002;106(12, Suppl 1):I143-I150.
39. Perry TE, Kaushal S, Sutherland FW, Guleserian KJ, Bischoff J, Sacks M, Mayer JE. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg 2003;75:761-767; discussion 767.
40. Rabkin E, Hoerstrup SP, Aikawa M, Mayer JE Jr, Schoen FJ. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis 2002;11:308-314; discussion 314.
41. Engelmayr GC Jr, Rabkin E, Sutherland FW, Schoen FJ, Mayer JE Jr, Sacks MS. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 2005;26:175-187.
42. Sutherland FW, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, Garcia GA, McLellan DL, Engelmayr GC Jr, Sacks MS, Schoen FJ, Mayer JE Jr. From stem cells to viable autologous semilunar heart valve. Circulation 2005;111:2783-2791.
43. Sodian R, Sperling JS, Martin DP, Egozy A, Stock U, Mayer JE Jr, Vacanti JP. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng 2000;6:183-188.
44. Sodian R, Hoerstrup SP, Sperling JS, Daebritz SH, Martin DP, Schoen FJ, Vacanti JP, Mayer JE Jr. Tissue engineering of heart valves: In vitro experiences. Ann Thorac Surg 2000;70:140-144.
45. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, Kim BS, Schoen FJ, Vacanti JP, Mayer JE Jr. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 2000;102(19 Suppl 3):III22-III29.
46. Nuttelman CR, Henry SM, Anseth KS. Synthesis and characterization of photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering scaffolds. Biomaterials 2002;23:3617-3626.
47. Masters KS, Shah DN, Walker G, Leinwand LA, Anseth KS. Designing scaffolds for valvular interstitial cells: Cell adhesion and function on naturally derived materials. J Biomed Mater Res A 2004;71:172-180.
48. Mei N, Chen G, Zhou P, Chen X, Shao ZZ, Pan LF, Wu CG. Biocompatibility of Poly(epsilon-caprolactone) scaffold modified by chitosan - The fibroblasts proliferation in vitro. J Biomater Appl 2005;19:323-339.
49. Curtil A, Pegg DE, Wilson A. Repopulation of freeze-dried porcine valves with human fibroblasts and endothelial cells. J Heart Valve Dis 1997;6:296-306.
50. Spina M, Ortolani F, Messlemani AE, Gandaglia A, Bujan J, Garcia-Honduvilla N, Vesely I, Gerosa G, Casarotto D, Petrelli L, Marchini M. Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: Extracellular matrix structure, prevention from calcification, and cell repopulation features. J Biomed Mater Res A 2003;67:1338-1350.
51. Dohmen PM, Ozaki S, Nitsch R, Yperman J, Flameng W, Konertz W. A tissue engineered heart valve implanted in a juvenile sheep model. Med Sci Monit 2003;9:97-104.
52. Leyh RG, Wilhelmi M, Walles T, Kallenbach K, Rebe P, Oberbeck A, Herden T, Haverich A, Mertsching H. Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus. J Thorac Cardiovasc Surg 2003;126:1000-1004.
53. Bertipaglia B, Ortolani F, Petrelli L, Gerosa G, Spina M, Pauletto P, Casarotto D, Marchini M, Sartore S. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: The VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann Thorac Surg 2003;75:1274-1282.
54. Stamm C, Khosravi A, Grabow N, Schmohl K, Treckmann N, Drechsel A, Nan M, Schmitz KP, Haubold A, Steinhoff G. Biomatrix/polymer composite material for heart valve tissue engineering. Ann Thorac Surg 2004;78:2084-2092; discussion 2083-2092.
55. Schenke-Layland K, Riemann I, Opitz F, Konig K, Halbhuber KJ, Stock UA. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol 2004;23:113-125.
56. Grauss RW, Hazekamp MG, Oppenhuizen F, van Munsteren CJ, Gittenberger-de Groot AC, DeRuiter MC. Histological evaluation of decellularised porcine aortic valves: Matrix changes due to different decellularisation methods. Eur J Cardiothorac Surg 2005;27:566-571.
57. Cushing MC, Jaeggli MP, Masters KS, Leinwand LA, Anseth KS. Serum deprivation improves seeding and repopulation of acellular matrices with valvular interstitial cells. J Biomed Mater Res A 2005;75:232-241.
58. Kasimir MT, Weigel G, Sharma J, Rieder E, Seebacher G, Wolner E, Simon P. The decellularized porcine heart valve matrix in tissue engineering: Platelet adhesion and activation. Thromb Haemost 2005;94:562-567.
59. Kasimir MT, Rieder E, Seebacher G, Nigisch A, Dekan B, Wolner E, Weigel G, Simon P. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis 2006;15:278-286; discussion 286.
60. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: In vivo restoration of valve tissue. Circulation 2000;102(19, Suppl 3):III50-III55.
61. Lichtenberg A, Cebotari S, Tudorache I, Sturz G, Winterhalter M, Hilfiker A, Haverich A. Flow-dependent re-endothelialization of tissue-engineered heart valves. J Heart Valve Dis 2006;15:287-293; discussion 284-293.
62. Lichtenberg A, Tudorache I, Cebotari S, Ringes-Lichtenberg S, Sturz G, Hoeffler K, Hurscheler C, Brandes G, Hilfiker A, Haverich A. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials 2006;27:4221-4229.
63. Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002;106(12, Suppl 1):163-168.
64. Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, Messmer BJ, Turina M. Fibrin gel - Advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2001;19:424-430.
65. Cimini M, Boughner DR, Ronald JA, Johnston DE, Rogers KA. Dermal fibroblasts cultured on small intestinal submucosa: Conditions for the formation of a neotissue. J Biomed Mater Res A 2005;75:895-906.
66. Masters KS, Shah DN, Leinwand LA, Anseth KS. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials 2005;26:2517-2525.
67. Rothenburger M, Vischer P, Volker W, Glasmacher B, Berendes E, Scheid HH, Deiwick M. In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. Thorac Cardiovasc Surg 2001;49:204-209.
68. Taylor PM, Allen SP, Dreger SA, Yacoub MH. Human cardiac valve interstitial cells in collagen sponge: A biological three-dimensional matrix for tissue engineering. J Heart Valve Dis 2002;11:298-306; discussion 297-306.
69. Butcher JT, Nerem RM. Porcine aortic valve interstitial cells in three-dimensional culture: Comparison of phenotype with aortic smooth muscle cells. J Heart Valve Dis 2004;13:478-485; discussion 476-485.
70. Taylor PM, Sachlos E, Dreger SA, Chester AH, Czernuszka JT, Yacoub MH. Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping. Biomaterials 2006;27:2733-2737.
71. Neidert MR, Tranquillo RT. Tissue-engineered valves with commissural alignment. Tissue Eng 2006;12:891-903.
72. Rothenburger M, Volker W, Vischer P, Glasmacher B, Scheld HH, Deiwick M. Ultrastructure of proteoglycans in tissue-engineered cardiovascular structures. Tissue Eng 2002;8:1049-1056.
73. Rothenburger M, Volker W, Vischer JP, Berendes E, Glasmacher B, Scheid HH, Deiwick M. Tissue engineering of heart valves: Formation of a three-dimensional tissue using porcine heart valve cells. ASAIO J 2002;48:586-591.
74. Shi Y, Ramamurthi A, Vesely I. Towards tissue engineering of a composite aortic valve. Biomed Sci Instrum 2002;38:35-40.
75. Cuy JL, Beckstead BL, Brown CD, Hoffman AS, Giachelli CM. Adhesive protein interactions with chitosan: Consequences for valve endothelial cell growth on tissue-engineering materials. J Biomed Mater Res A 2003;67:538-547.
76. Flanagan TC, Wilkins B, Black A, Jockenhoevel S, Smith TJ, Pandit AS. A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications. Biomaterials 2006;27:2233-2246.
77. Shi G, Wang C, Lu N, Wang S, Bei J. Fabrication of cell scaffolds of poly(L-lactic acid) and poly(L-lactic-co-glycolic acid). Polym Adv Technol 2002;13:227.
78. Breuer CK, Mettler BA, Anthony T, Sales VL, Schoen FJ, Mayer JE. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng 2004;10:1725-1736.
79. Badylak SF. Regenerative medicine approach to heart valve replacement. Circulation 2005;111:2715-2716.
80. Ozawa T, Mickle DA, Weisel RD, Matsubayashi K, Fujii T, Fedak PW, Koyama N, Ikada Y, Li RK. Tissue-engineered grafts matured in the right ventricular outflow tract. Cell Transplant 2004;13:169-177.
81. Webb AR, Yang J, Ameer GA. Biodegradable polyester elastomers in tissue engineering. Expert Opin Biol Ther 2004;4:801-812.
82. Murray G. Homologous aortic-valve-segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology 1956;7:466-471.
83. Martin U, Winkler ME, Id M, Radeke H, Arseniev L, Takeuchi Y, Simon AR, Patience C, Haverich A, Steinhoff G. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 2000;7:138-142.
84. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3:282-286.
85. Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998;72:3082-3087.
86. Moza AK, Mertsching H, Herden T, Bader A, Haverich A. Heart valves from pigs and the porcine endogenous retrovirus: Experimental and clinical data to assess the probability of porcine endogenous retrovirus infection in human subjects. J Thorac Cardiovasc Surg 2001;121:697-701.
87. Curtil A, Pegg DE, Wilson A. Freeze drying of cardiac valves in preparation for cellular repopulation. Cryobiology 1997;34:13-22.
88. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 1995;60(2 Suppl):S353-S358.
89. Brenner S, Schulz T, Schenke-Layland K, Opitz F, Halbhuber KJ, Stock U. Continued proteolitic activity in decellularised porcine heart valves. In: Advances in Tissue Engineering and Biology of Heart Valves. Florence, Italy, September 15-18, 2004. p 101.
90. Gu CH, Liu WY, Yi DH, Wang YY, Zhang JB, Wei XY. Ouyang H, Liu XG, Tan HM. Effects of modified acellularization process on porcine endogenous retroviruses in porcine aorta valves. Zhonghua Yi Xue Za Zhi 2005;85:1827-1830.
91. Galili U. The α-gal epitope (Gal α 1-3Gal β 1-4GlcNAc-R) in xenotransplantation. Biochimie 2001;83:557-563.
92. Grabow N, Schmohl K, Khosravi A, Philipp M, Scharfschwerdt M, Graf B, Stamm C, Haubold A, Schmitz KP, Steinhoff G. Mechanical and structural properties of a novel hybrid heart valve scaffold for tissue engineering. Artif Organs 2004;28:971-979.
93. Schmidt CE, Baier JM. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000;21:2215-2231.
94. Vesely I. The role of elastin in aortic valve mechanics. J Biomech 1998;31:115-123.
95. Chevallay B, Herbage D. Collagen-based biomaterials as 3D scaffold for cell cultures: Applications for tissue engineering and gene therapy. Med Biol Eng Comput 2000;38:211-218.
96. Suh JK, Matthew HW. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review. Biomaterials 2000;21:2589-2598.
97. Elcin YM, Dixit V, Gitnick G. Hepatocyte attachment on biodegradable modified chitosan membranes: In vitro evaluation for the development of liver organoids. Artif Organs 1998;22:837-846.
98. Sierra DH. Fibrin sealant adhesive systems: A review of their chemistry, material properties and clinical applications. J Biomater Appl 1993;7:309-352.
99. Hubbell JA. Bioactive biomaterials. Curr Opin Biotechnol 1999;10:123-129.
100. Hubbell JA. Biomaterials in tissue engineering. Biotechnology (NY) 1995;13:565-576.
101. Lewis KB, Teller DC, Fry J, Lasser GW, Bishop PD. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and γ-chain peptides. Biochemistry 1997;36:995-1002.
102. Jockenhoevel S, Chalabi K, Sachweh JS, Groesdonk HV, Demircan L, Grossmann M, Zund G, Messmer BJ. Tissue engineering: Complete autologous valve conduit - A new moulding technique. Thorac Cardiovasc Surg 2001;49:287-290.
103. Crescenzi V, Francescangeli A, Renier D, Bellini D. New cross-linked and sulfated derivatives of partially deacetylated hyaluronan: Synthesis and preliminary characterization. Biopolymers 2002;64:86-94.
104. Smeds KA, Pfister-Serres A, Miki D, Dastgheib K, Inoue M, Hatchell DL, Grinstaff MW. Photocrosslinkable polysaccharides for in situ hydrogel formation. J Biomed Mater Res 2001;54:115-121.
105. Baier Leach J, Bivens KA, Patrick CW Jr, Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003;82:578-589.
106. Ramamurthi A, Vesely I. Smooth muscle cell adhesion on crosslinked hyaluronan gels. J Biomed Mater Res A 2002;60:195-205.
107. Ramamurthi A, Vesely I. Ultraviolet light-induced modification of crosslinked hyaluronan gels. J Biomed Mater Res A 2003;66:317-329.